Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Top 10 Neuroscience Projects To Watch 2013 14"

15:42 EDT 23rd April 2014 | BioPortfolio

Matching Channels

Mesenchymal Epithelial Transition factor c MET

The c-MET signalling pathway consists of the mesenchymal epithelial transition factor (c-MET) transmembrane tyrosine kinase receptor and its ligand hepatocyte growth factor (HGF) or scatter factor (SF...

AstraZeneca

AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and em...

Staphylococcal aureus infections

Staphylococcal aureus infections represent an enormous burden to public health systems. Traditionally restricted to the hospital setting as nosocomial infections, highly virulent strains have recently...

Merck and Co

Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the...

Lilly

Eli Lilly and Company was founded in 1876, and is now the 9th largest pharmaceutical company based an annual sales which were just under $20bn in 2009. Orginally from the USA, Lilly now operates in...

Matching News

Genelux project named one of 2013's Top Oncology Projects to Watch

Genelux, a privately-held, clinical stage biopharmaceutical company, has announced the company's lead product candidate, GL-ONC1, has been selected by Elsevier Business Intelligence, a global provider...

BioArctic Neuroscience AB - Product Pipeline Review - 2013

Recently added to the BioPortfolio report store, BioArctic Neuroscience AB - Product Pipeline Review - 2013 is a new report from Global Markets Direct published on 2013-10-30. This 21-page report is...

Neuroscience companies sprout up in Boston

TweetIn our December 10, 2013 blog article that focused on Novartis’ new neuroscience division, we briefly mentioned two young Cambridge MA neuroscience specialty companies–Rodin Therapeut...

ScienceOnline San Diego November 12th 2013 Event Downtown: You’ve Published Your Results, Now Build Your Community

The San Diego Biotechnology Network is involved with the local ScienceOnline San Diego chapter and we are thrilled to help promote an event downtown coinciding with the Society for Neuroscience 2013 (...

The Most Promising Drugs to Watch Changing Phase and Receiving Approval Q4 2013

The latest The Ones to Watch report is an expert review of the most promising drugs to watch launched from October to December 2013. These pharmaceuticals are changing clinical phase and receiving app...

Market Insight: Drugs to Watch in 2014

Last year, Thomson Reuters Cortellis Competitive Intelligence highlighted five drugs to watch that were predicted to achieve significant regulatory milestones that year and make sales of over $1 billi...

PoolMate Lap Counting Watch Introduction Video Released on SwimovateUSA.com

(PRWEB) November 24, 2013 A lap counting watch introduction video was recently released on SwimovateUSA.com from the original makers of automatic lap counting watches . The video shows the watc...

Companies To Watch: A Roundup Of Life Science Developments And Technologies

Each month, Companies to Watch spotlights one company that has received scant press coverage but, nonetheless, contains an especially interesting story. At the end of this past year, we thought it wou...

Matching PubMed Articles

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement